Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:21 AM
Ignite Modification Date:
2025-12-25 @ 12:21 AM
NCT ID:
NCT00410358
Eligibility Criteria:
Inclusion Criteria:
* Patients with histological or cytological confirmed advanced solid tumors, which have progressed despite standard therapy or for whom no standard therapy exists.
* Life expectancy of at least 3 months
* Adequate hematological parameters
* No major impairment of renal and hepatic function
Exclusion Criteria:
* Gastrointestinal dysfunction, such as gastrectomy and malabsorption syndrome that could alter absorption.
* Patients who have received any investigational compound within the past 28 days.
* Patients with other antineoplastic therapy within the last 28 days.
* Patients known to be HIV or hepatitis virus positive, or patients with the presence of active or suspected acute or chronic uncontrolled infection
* Patients with a history of allergies to the camptothecin family drug.
Other protocol-defined inclusion/exclusion criteria may apply
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Study:
NCT00410358
Study Brief:
Protocol Section:
NCT00410358